nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ankylosing spondylitis—osteoporosis	0.3	1	CtDrD
Dexamethasone—CYP19A1—osteoporosis	0.108	1	CbGaD
Dexamethasone—breast cancer—Estradiol—osteoporosis	0.1	0.363	CpDpCtD
Dexamethasone—breast cancer—Conjugated Estrogens—osteoporosis	0.1	0.363	CpDpCtD
Dexamethasone—breast cancer—Ethinyl Estradiol—osteoporosis	0.076	0.275	CpDpCtD
Dexamethasone—CYP11A1—Cholecalciferol—osteoporosis	0.0232	0.109	CbGbCtD
Dexamethasone—PTGS2—Risedronate—osteoporosis	0.0177	0.0837	CbGbCtD
Dexamethasone—ABCB11—Ethinyl Estradiol—osteoporosis	0.0167	0.0786	CbGbCtD
Dexamethasone—CYP19A1—Raloxifene—osteoporosis	0.014	0.066	CbGbCtD
Dexamethasone—CYP1B1—Estradiol—osteoporosis	0.0107	0.0507	CbGbCtD
Dexamethasone—ABCC2—Ethinyl Estradiol—osteoporosis	0.00876	0.0413	CbGbCtD
Dexamethasone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.00775	0.0366	CbGbCtD
Dexamethasone—SLCO1A2—Estradiol—osteoporosis	0.00681	0.0321	CbGbCtD
Dexamethasone—ABCC2—Conjugated Estrogens—osteoporosis	0.00643	0.0303	CbGbCtD
Dexamethasone—CYP1A1—Cholecalciferol—osteoporosis	0.00584	0.0276	CbGbCtD
Dexamethasone—ABCG2—Conjugated Estrogens—osteoporosis	0.00581	0.0274	CbGbCtD
Dexamethasone—CYP2B6—Raloxifene—osteoporosis	0.00576	0.0272	CbGbCtD
Dexamethasone—CYP2B6—Ethinyl Estradiol—osteoporosis	0.00557	0.0263	CbGbCtD
Dexamethasone—ABCG2—Estradiol—osteoporosis	0.0051	0.0241	CbGbCtD
Dexamethasone—CYP1A1—Estradiol—osteoporosis	0.00471	0.0222	CbGbCtD
Dexamethasone—CYP2C9—Estropipate—osteoporosis	0.00456	0.0216	CbGbCtD
Dexamethasone—CYP2B6—Cholecalciferol—osteoporosis	0.00445	0.021	CbGbCtD
Dexamethasone—CYP2C8—Raloxifene—osteoporosis	0.00437	0.0206	CbGbCtD
Dexamethasone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.00422	0.0199	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.00377	0.0178	CbGbCtD
Dexamethasone—CYP3A7—Estradiol—osteoporosis	0.00377	0.0178	CbGbCtD
Dexamethasone—CYP2C8—Cholecalciferol—osteoporosis	0.00337	0.0159	CbGbCtD
Dexamethasone—ABCB1—Ethinyl Estradiol—osteoporosis	0.00285	0.0135	CbGbCtD
Dexamethasone—CYP2C19—Cholecalciferol—osteoporosis	0.00283	0.0134	CbGbCtD
Dexamethasone—CYP3A5—Estradiol—osteoporosis	0.00283	0.0133	CbGbCtD
Dexamethasone—CYP2C8—Estradiol—osteoporosis	0.00272	0.0128	CbGbCtD
Dexamethasone—CYP3A4—Estropipate—osteoporosis	0.00265	0.0125	CbGbCtD
Dexamethasone—CYP3A4—Calcitriol—osteoporosis	0.00265	0.0125	CbGbCtD
Dexamethasone—CYP2C9—Cholecalciferol—osteoporosis	0.00235	0.0111	CbGbCtD
Dexamethasone—CYP2C19—Estradiol—osteoporosis	0.00228	0.0108	CbGbCtD
Dexamethasone—CYP2D6—Cholecalciferol—osteoporosis	0.00215	0.0102	CbGbCtD
Dexamethasone—CYP3A4—Ergocalciferol—osteoporosis	0.00212	0.01	CbGbCtD
Dexamethasone—ABCB1—Conjugated Estrogens—osteoporosis	0.0021	0.00989	CbGbCtD
Dexamethasone—CYP2C9—Estradiol—osteoporosis	0.0019	0.00895	CbGbCtD
Dexamethasone—ABCB1—Estradiol—osteoporosis	0.00184	0.00869	CbGbCtD
Dexamethasone—CYP3A4—Raloxifene—osteoporosis	0.00177	0.00836	CbGbCtD
Dexamethasone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00171	0.00808	CbGbCtD
Dexamethasone—CYP3A4—Cholecalciferol—osteoporosis	0.00137	0.00646	CbGbCtD
Dexamethasone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00126	0.00593	CbGbCtD
Dexamethasone—CYP3A4—Estradiol—osteoporosis	0.0011	0.0052	CbGbCtD
Dexamethasone—Testolactone—CYP19A1—osteoporosis	0.000226	0.338	CrCbGaD
Dexamethasone—Fluoxymesterone—SHBG—osteoporosis	0.000155	0.232	CrCbGaD
Dexamethasone—Fluoxymesterone—ESR1—osteoporosis	0.000105	0.157	CrCbGaD
Dexamethasone—Hydrocortisone—SHBG—osteoporosis	9.42e-05	0.141	CrCbGaD
Dexamethasone—Betamethasone—CYP19A1—osteoporosis	8.86e-05	0.133	CrCbGaD
Dexamethasone—Nervous system disorder—Risedronate—osteoporosis	4.49e-05	0.000676	CcSEcCtD
Dexamethasone—Discomfort—Pamidronate—osteoporosis	4.48e-05	0.000675	CcSEcCtD
Dexamethasone—Angioedema—Zoledronate—osteoporosis	4.45e-05	0.00067	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Calcitriol—osteoporosis	4.44e-05	0.00067	CcSEcCtD
Dexamethasone—Abdominal pain—Raloxifene—osteoporosis	4.43e-05	0.000668	CcSEcCtD
Dexamethasone—Body temperature increased—Raloxifene—osteoporosis	4.43e-05	0.000668	CcSEcCtD
Dexamethasone—Urticaria—Ibandronate—osteoporosis	4.41e-05	0.000664	CcSEcCtD
Dexamethasone—Malaise—Zoledronate—osteoporosis	4.39e-05	0.000661	CcSEcCtD
Dexamethasone—Body temperature increased—Ibandronate—osteoporosis	4.39e-05	0.000661	CcSEcCtD
Dexamethasone—Abdominal pain—Ibandronate—osteoporosis	4.39e-05	0.000661	CcSEcCtD
Dexamethasone—Vertigo—Zoledronate—osteoporosis	4.37e-05	0.000659	CcSEcCtD
Dexamethasone—Syncope—Zoledronate—osteoporosis	4.37e-05	0.000658	CcSEcCtD
Dexamethasone—Oedema—Pamidronate—osteoporosis	4.35e-05	0.000655	CcSEcCtD
Dexamethasone—Anaphylactic shock—Pamidronate—osteoporosis	4.35e-05	0.000655	CcSEcCtD
Dexamethasone—Haemoglobin—Estradiol—osteoporosis	4.33e-05	0.000653	CcSEcCtD
Dexamethasone—Infection—Pamidronate—osteoporosis	4.32e-05	0.000651	CcSEcCtD
Dexamethasone—Urticaria—Calcitriol—osteoporosis	4.32e-05	0.00065	CcSEcCtD
Dexamethasone—Haemorrhage—Estradiol—osteoporosis	4.31e-05	0.000649	CcSEcCtD
Dexamethasone—Abdominal pain—Calcitriol—osteoporosis	4.3e-05	0.000647	CcSEcCtD
Dexamethasone—Body temperature increased—Calcitriol—osteoporosis	4.3e-05	0.000647	CcSEcCtD
Dexamethasone—Angioedema—Conjugated Estrogens—osteoporosis	4.28e-05	0.000645	CcSEcCtD
Dexamethasone—Shock—Pamidronate—osteoporosis	4.28e-05	0.000645	CcSEcCtD
Dexamethasone—Loss of consciousness—Zoledronate—osteoporosis	4.28e-05	0.000645	CcSEcCtD
Dexamethasone—Nervous system disorder—Pamidronate—osteoporosis	4.27e-05	0.000643	CcSEcCtD
Dexamethasone—Thrombocytopenia—Pamidronate—osteoporosis	4.26e-05	0.000642	CcSEcCtD
Dexamethasone—Vomiting—Etidronic acid—osteoporosis	4.26e-05	0.000641	CcSEcCtD
Dexamethasone—Tachycardia—Pamidronate—osteoporosis	4.25e-05	0.00064	CcSEcCtD
Dexamethasone—Rash—Etidronic acid—osteoporosis	4.22e-05	0.000636	CcSEcCtD
Dexamethasone—Convulsion—Zoledronate—osteoporosis	4.22e-05	0.000635	CcSEcCtD
Dexamethasone—Dermatitis—Etidronic acid—osteoporosis	4.22e-05	0.000635	CcSEcCtD
Dexamethasone—Vertigo—Conjugated Estrogens—osteoporosis	4.21e-05	0.000634	CcSEcCtD
Dexamethasone—Hyperhidrosis—Pamidronate—osteoporosis	4.2e-05	0.000633	CcSEcCtD
Dexamethasone—Syncope—Conjugated Estrogens—osteoporosis	4.2e-05	0.000633	CcSEcCtD
Dexamethasone—Hypertension—Zoledronate—osteoporosis	4.2e-05	0.000633	CcSEcCtD
Dexamethasone—Headache—Etidronic acid—osteoporosis	4.19e-05	0.000632	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Risedronate—osteoporosis	4.17e-05	0.000628	CcSEcCtD
Dexamethasone—Asthenia—Estropipate—osteoporosis	4.15e-05	0.000626	CcSEcCtD
Dexamethasone—Visual impairment—Estradiol—osteoporosis	4.15e-05	0.000626	CcSEcCtD
Dexamethasone—Anorexia—Pamidronate—osteoporosis	4.15e-05	0.000625	CcSEcCtD
Dexamethasone—Myalgia—Zoledronate—osteoporosis	4.14e-05	0.000624	CcSEcCtD
Dexamethasone—Insomnia—Risedronate—osteoporosis	4.14e-05	0.000623	CcSEcCtD
Dexamethasone—Anxiety—Zoledronate—osteoporosis	4.13e-05	0.000622	CcSEcCtD
Dexamethasone—Loss of consciousness—Conjugated Estrogens—osteoporosis	4.12e-05	0.000621	CcSEcCtD
Dexamethasone—Paraesthesia—Risedronate—osteoporosis	4.11e-05	0.000619	CcSEcCtD
Dexamethasone—Pruritus—Estropipate—osteoporosis	4.1e-05	0.000617	CcSEcCtD
Dexamethasone—Discomfort—Zoledronate—osteoporosis	4.09e-05	0.000617	CcSEcCtD
Dexamethasone—Asthenia—Alendronate—osteoporosis	4.09e-05	0.000616	CcSEcCtD
Dexamethasone—Hypotension—Pamidronate—osteoporosis	4.06e-05	0.000612	CcSEcCtD
Dexamethasone—Convulsion—Conjugated Estrogens—osteoporosis	4.06e-05	0.000612	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	4.05e-05	0.00061	CcSEcCtD
Dexamethasone—Fatigue—Ethinyl Estradiol—osteoporosis	4.05e-05	0.00061	CcSEcCtD
Dexamethasone—Pruritus—Alendronate—osteoporosis	4.03e-05	0.000608	CcSEcCtD
Dexamethasone—Dyspepsia—Risedronate—osteoporosis	4.03e-05	0.000607	CcSEcCtD
Dexamethasone—Eye disorder—Estradiol—osteoporosis	4.03e-05	0.000607	CcSEcCtD
Dexamethasone—Myalgia—Conjugated Estrogens—osteoporosis	3.99e-05	0.000601	CcSEcCtD
Dexamethasone—Asthenia—Ibandronate—osteoporosis	3.98e-05	0.0006	CcSEcCtD
Dexamethasone—Anxiety—Conjugated Estrogens—osteoporosis	3.98e-05	0.000599	CcSEcCtD
Dexamethasone—Nausea—Etidronic acid—osteoporosis	3.98e-05	0.000599	CcSEcCtD
Dexamethasone—Oedema—Zoledronate—osteoporosis	3.97e-05	0.000599	CcSEcCtD
Dexamethasone—Anaphylactic shock—Zoledronate—osteoporosis	3.97e-05	0.000599	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Pamidronate—osteoporosis	3.96e-05	0.000597	CcSEcCtD
Dexamethasone—Diarrhoea—Estropipate—osteoporosis	3.96e-05	0.000597	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Risedronate—osteoporosis	3.95e-05	0.000595	CcSEcCtD
Dexamethasone—Infection—Zoledronate—osteoporosis	3.95e-05	0.000595	CcSEcCtD
Dexamethasone—Fatigue—Risedronate—osteoporosis	3.94e-05	0.000594	CcSEcCtD
Dexamethasone—Insomnia—Pamidronate—osteoporosis	3.93e-05	0.000593	CcSEcCtD
Dexamethasone—Pruritus—Ibandronate—osteoporosis	3.93e-05	0.000592	CcSEcCtD
Dexamethasone—Pain—Risedronate—osteoporosis	3.91e-05	0.000589	CcSEcCtD
Dexamethasone—Angiopathy—Estradiol—osteoporosis	3.91e-05	0.000589	CcSEcCtD
Dexamethasone—Shock—Zoledronate—osteoporosis	3.91e-05	0.000589	CcSEcCtD
Dexamethasone—Paraesthesia—Pamidronate—osteoporosis	3.91e-05	0.000588	CcSEcCtD
Dexamethasone—Diarrhoea—Alendronate—osteoporosis	3.9e-05	0.000588	CcSEcCtD
Dexamethasone—Asthenia—Calcitriol—osteoporosis	3.9e-05	0.000587	CcSEcCtD
Dexamethasone—Nervous system disorder—Zoledronate—osteoporosis	3.9e-05	0.000587	CcSEcCtD
Dexamethasone—Thrombocytopenia—Zoledronate—osteoporosis	3.89e-05	0.000586	CcSEcCtD
Dexamethasone—Tachycardia—Zoledronate—osteoporosis	3.88e-05	0.000584	CcSEcCtD
Dexamethasone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	3.87e-05	0.000583	CcSEcCtD
Dexamethasone—Pruritus—Calcitriol—osteoporosis	3.85e-05	0.000579	CcSEcCtD
Dexamethasone—Hyperhidrosis—Zoledronate—osteoporosis	3.84e-05	0.000579	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	3.84e-05	0.000578	CcSEcCtD
Dexamethasone—Diarrhoea—Raloxifene—osteoporosis	3.84e-05	0.000578	CcSEcCtD
Dexamethasone—Dyspepsia—Pamidronate—osteoporosis	3.83e-05	0.000577	CcSEcCtD
Dexamethasone—Dizziness—Estropipate—osteoporosis	3.83e-05	0.000577	CcSEcCtD
Dexamethasone—Oedema—Conjugated Estrogens—osteoporosis	3.83e-05	0.000576	CcSEcCtD
Dexamethasone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	3.83e-05	0.000576	CcSEcCtD
Dexamethasone—Alopecia—Estradiol—osteoporosis	3.81e-05	0.000574	CcSEcCtD
Dexamethasone—Infection—Conjugated Estrogens—osteoporosis	3.8e-05	0.000573	CcSEcCtD
Dexamethasone—Diarrhoea—Ibandronate—osteoporosis	3.8e-05	0.000572	CcSEcCtD
Dexamethasone—Anorexia—Zoledronate—osteoporosis	3.79e-05	0.000571	CcSEcCtD
Dexamethasone—Decreased appetite—Pamidronate—osteoporosis	3.78e-05	0.00057	CcSEcCtD
Dexamethasone—Dizziness—Alendronate—osteoporosis	3.77e-05	0.000568	CcSEcCtD
Dexamethasone—Shock—Conjugated Estrogens—osteoporosis	3.76e-05	0.000567	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Pamidronate—osteoporosis	3.76e-05	0.000566	CcSEcCtD
Dexamethasone—Nervous system disorder—Conjugated Estrogens—osteoporosis	3.75e-05	0.000565	CcSEcCtD
Dexamethasone—Erythema—Estradiol—osteoporosis	3.75e-05	0.000565	CcSEcCtD
Dexamethasone—Fatigue—Pamidronate—osteoporosis	3.75e-05	0.000565	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Risedronate—osteoporosis	3.74e-05	0.000564	CcSEcCtD
Dexamethasone—Tachycardia—Conjugated Estrogens—osteoporosis	3.73e-05	0.000562	CcSEcCtD
Dexamethasone—Urticaria—Ethinyl Estradiol—osteoporosis	3.73e-05	0.000562	CcSEcCtD
Dexamethasone—Pain—Pamidronate—osteoporosis	3.72e-05	0.00056	CcSEcCtD
Dexamethasone—Diarrhoea—Calcitriol—osteoporosis	3.72e-05	0.00056	CcSEcCtD
Dexamethasone—Hypotension—Zoledronate—osteoporosis	3.71e-05	0.000559	CcSEcCtD
Dexamethasone—Abdominal pain—Ethinyl Estradiol—osteoporosis	3.71e-05	0.000559	CcSEcCtD
Dexamethasone—Body temperature increased—Ethinyl Estradiol—osteoporosis	3.71e-05	0.000559	CcSEcCtD
Dexamethasone—Dizziness—Raloxifene—osteoporosis	3.71e-05	0.000559	CcSEcCtD
Dexamethasone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	3.7e-05	0.000557	CcSEcCtD
Dexamethasone—Vomiting—Estropipate—osteoporosis	3.68e-05	0.000555	CcSEcCtD
Dexamethasone—Dizziness—Ibandronate—osteoporosis	3.67e-05	0.000553	CcSEcCtD
Dexamethasone—Rash—Estropipate—osteoporosis	3.65e-05	0.00055	CcSEcCtD
Dexamethasone—Dermatitis—Estropipate—osteoporosis	3.65e-05	0.000549	CcSEcCtD
Dexamethasone—Anorexia—Conjugated Estrogens—osteoporosis	3.65e-05	0.000549	CcSEcCtD
Dexamethasone—Urticaria—Risedronate—osteoporosis	3.63e-05	0.000548	CcSEcCtD
Dexamethasone—Headache—Estropipate—osteoporosis	3.63e-05	0.000546	CcSEcCtD
Dexamethasone—Vomiting—Alendronate—osteoporosis	3.63e-05	0.000546	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Zoledronate—osteoporosis	3.62e-05	0.000545	CcSEcCtD
Dexamethasone—Abdominal pain—Risedronate—osteoporosis	3.62e-05	0.000545	CcSEcCtD
Dexamethasone—Body temperature increased—Risedronate—osteoporosis	3.62e-05	0.000545	CcSEcCtD
Dexamethasone—Rash—Alendronate—osteoporosis	3.6e-05	0.000542	CcSEcCtD
Dexamethasone—Insomnia—Zoledronate—osteoporosis	3.59e-05	0.000541	CcSEcCtD
Dexamethasone—Dermatitis—Alendronate—osteoporosis	3.59e-05	0.000541	CcSEcCtD
Dexamethasone—Feeling abnormal—Pamidronate—osteoporosis	3.58e-05	0.00054	CcSEcCtD
Dexamethasone—Hypotension—Conjugated Estrogens—osteoporosis	3.57e-05	0.000539	CcSEcCtD
Dexamethasone—Headache—Alendronate—osteoporosis	3.57e-05	0.000538	CcSEcCtD
Dexamethasone—Paraesthesia—Zoledronate—osteoporosis	3.57e-05	0.000537	CcSEcCtD
Dexamethasone—Vomiting—Raloxifene—osteoporosis	3.57e-05	0.000537	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Pamidronate—osteoporosis	3.56e-05	0.000536	CcSEcCtD
Dexamethasone—Rash—Raloxifene—osteoporosis	3.54e-05	0.000533	CcSEcCtD
Dexamethasone—Dermatitis—Raloxifene—osteoporosis	3.53e-05	0.000532	CcSEcCtD
Dexamethasone—Vomiting—Ibandronate—osteoporosis	3.53e-05	0.000532	CcSEcCtD
Dexamethasone—Headache—Raloxifene—osteoporosis	3.51e-05	0.000529	CcSEcCtD
Dexamethasone—Rash—Ibandronate—osteoporosis	3.5e-05	0.000527	CcSEcCtD
Dexamethasone—Dermatitis—Ibandronate—osteoporosis	3.5e-05	0.000527	CcSEcCtD
Dexamethasone—Dyspepsia—Zoledronate—osteoporosis	3.5e-05	0.000527	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	3.49e-05	0.000525	CcSEcCtD
Dexamethasone—Ill-defined disorder—Estradiol—osteoporosis	3.48e-05	0.000524	CcSEcCtD
Dexamethasone—Headache—Ibandronate—osteoporosis	3.48e-05	0.000524	CcSEcCtD
Dexamethasone—Insomnia—Conjugated Estrogens—osteoporosis	3.46e-05	0.000521	CcSEcCtD
Dexamethasone—Vomiting—Calcitriol—osteoporosis	3.46e-05	0.000521	CcSEcCtD
Dexamethasone—Decreased appetite—Zoledronate—osteoporosis	3.45e-05	0.00052	CcSEcCtD
Dexamethasone—Nausea—Estropipate—osteoporosis	3.44e-05	0.000518	CcSEcCtD
Dexamethasone—Abdominal pain—Pamidronate—osteoporosis	3.44e-05	0.000518	CcSEcCtD
Dexamethasone—Body temperature increased—Pamidronate—osteoporosis	3.44e-05	0.000518	CcSEcCtD
Dexamethasone—Paraesthesia—Conjugated Estrogens—osteoporosis	3.44e-05	0.000518	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Zoledronate—osteoporosis	3.43e-05	0.000517	CcSEcCtD
Dexamethasone—Angioedema—Estradiol—osteoporosis	3.43e-05	0.000516	CcSEcCtD
Dexamethasone—Rash—Calcitriol—osteoporosis	3.43e-05	0.000516	CcSEcCtD
Dexamethasone—Fatigue—Zoledronate—osteoporosis	3.43e-05	0.000516	CcSEcCtD
Dexamethasone—Dermatitis—Calcitriol—osteoporosis	3.42e-05	0.000516	CcSEcCtD
Dexamethasone—Headache—Calcitriol—osteoporosis	3.4e-05	0.000513	CcSEcCtD
Dexamethasone—Pain—Zoledronate—osteoporosis	3.4e-05	0.000512	CcSEcCtD
Dexamethasone—Nausea—Alendronate—osteoporosis	3.39e-05	0.00051	CcSEcCtD
Dexamethasone—Malaise—Estradiol—osteoporosis	3.38e-05	0.00051	CcSEcCtD
Dexamethasone—Vertigo—Estradiol—osteoporosis	3.37e-05	0.000508	CcSEcCtD
Dexamethasone—Dyspepsia—Conjugated Estrogens—osteoporosis	3.37e-05	0.000507	CcSEcCtD
Dexamethasone—Asthenia—Ethinyl Estradiol—osteoporosis	3.37e-05	0.000507	CcSEcCtD
Dexamethasone—Syncope—Estradiol—osteoporosis	3.36e-05	0.000507	CcSEcCtD
Dexamethasone—Nausea—Raloxifene—osteoporosis	3.33e-05	0.000502	CcSEcCtD
Dexamethasone—Decreased appetite—Conjugated Estrogens—osteoporosis	3.33e-05	0.000501	CcSEcCtD
Dexamethasone—Pruritus—Ethinyl Estradiol—osteoporosis	3.32e-05	0.0005	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	3.3e-05	0.000498	CcSEcCtD
Dexamethasone—Fatigue—Conjugated Estrogens—osteoporosis	3.3e-05	0.000497	CcSEcCtD
Dexamethasone—Nausea—Ibandronate—osteoporosis	3.3e-05	0.000497	CcSEcCtD
Dexamethasone—Loss of consciousness—Estradiol—osteoporosis	3.3e-05	0.000497	CcSEcCtD
Dexamethasone—Asthenia—Risedronate—osteoporosis	3.28e-05	0.000495	CcSEcCtD
Dexamethasone—Feeling abnormal—Zoledronate—osteoporosis	3.27e-05	0.000493	CcSEcCtD
Dexamethasone—Pain—Conjugated Estrogens—osteoporosis	3.27e-05	0.000493	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Zoledronate—osteoporosis	3.25e-05	0.000489	CcSEcCtD
Dexamethasone—Hypertension—Estradiol—osteoporosis	3.24e-05	0.000488	CcSEcCtD
Dexamethasone—Pruritus—Risedronate—osteoporosis	3.24e-05	0.000488	CcSEcCtD
Dexamethasone—Nausea—Calcitriol—osteoporosis	3.23e-05	0.000486	CcSEcCtD
Dexamethasone—Diarrhoea—Ethinyl Estradiol—osteoporosis	3.21e-05	0.000484	CcSEcCtD
Dexamethasone—Myalgia—Estradiol—osteoporosis	3.19e-05	0.000481	CcSEcCtD
Dexamethasone—Anxiety—Estradiol—osteoporosis	3.18e-05	0.00048	CcSEcCtD
Dexamethasone—Urticaria—Zoledronate—osteoporosis	3.16e-05	0.000476	CcSEcCtD
Dexamethasone—Discomfort—Estradiol—osteoporosis	3.16e-05	0.000475	CcSEcCtD
Dexamethasone—Abdominal pain—Zoledronate—osteoporosis	3.14e-05	0.000473	CcSEcCtD
Dexamethasone—Body temperature increased—Zoledronate—osteoporosis	3.14e-05	0.000473	CcSEcCtD
Dexamethasone—Diarrhoea—Risedronate—osteoporosis	3.13e-05	0.000472	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	3.13e-05	0.000471	CcSEcCtD
Dexamethasone—Asthenia—Pamidronate—osteoporosis	3.12e-05	0.00047	CcSEcCtD
Dexamethasone—Dizziness—Ethinyl Estradiol—osteoporosis	3.1e-05	0.000468	CcSEcCtD
Dexamethasone—Pruritus—Pamidronate—osteoporosis	3.08e-05	0.000464	CcSEcCtD
Dexamethasone—Oedema—Estradiol—osteoporosis	3.06e-05	0.000461	CcSEcCtD
Dexamethasone—Anaphylactic shock—Estradiol—osteoporosis	3.06e-05	0.000461	CcSEcCtD
Dexamethasone—Infection—Estradiol—osteoporosis	3.04e-05	0.000458	CcSEcCtD
Dexamethasone—Urticaria—Conjugated Estrogens—osteoporosis	3.04e-05	0.000458	CcSEcCtD
Dexamethasone—Dizziness—Risedronate—osteoporosis	3.03e-05	0.000456	CcSEcCtD
Dexamethasone—Abdominal pain—Conjugated Estrogens—osteoporosis	3.02e-05	0.000456	CcSEcCtD
Dexamethasone—Body temperature increased—Conjugated Estrogens—osteoporosis	3.02e-05	0.000456	CcSEcCtD
Dexamethasone—Shock—Estradiol—osteoporosis	3.01e-05	0.000454	CcSEcCtD
Dexamethasone—Nervous system disorder—Estradiol—osteoporosis	3e-05	0.000452	CcSEcCtD
Dexamethasone—Tachycardia—Estradiol—osteoporosis	2.99e-05	0.00045	CcSEcCtD
Dexamethasone—Vomiting—Ethinyl Estradiol—osteoporosis	2.98e-05	0.00045	CcSEcCtD
Dexamethasone—Diarrhoea—Pamidronate—osteoporosis	2.98e-05	0.000448	CcSEcCtD
Dexamethasone—Hyperhidrosis—Estradiol—osteoporosis	2.96e-05	0.000446	CcSEcCtD
Dexamethasone—Rash—Ethinyl Estradiol—osteoporosis	2.96e-05	0.000446	CcSEcCtD
Dexamethasone—Dermatitis—Ethinyl Estradiol—osteoporosis	2.96e-05	0.000445	CcSEcCtD
Dexamethasone—Headache—Ethinyl Estradiol—osteoporosis	2.94e-05	0.000443	CcSEcCtD
Dexamethasone—Vomiting—Risedronate—osteoporosis	2.91e-05	0.000438	CcSEcCtD
Dexamethasone—Rash—Risedronate—osteoporosis	2.88e-05	0.000435	CcSEcCtD
Dexamethasone—Dermatitis—Risedronate—osteoporosis	2.88e-05	0.000434	CcSEcCtD
Dexamethasone—Dizziness—Pamidronate—osteoporosis	2.88e-05	0.000433	CcSEcCtD
Dexamethasone—Headache—Risedronate—osteoporosis	2.87e-05	0.000432	CcSEcCtD
Dexamethasone—Asthenia—Zoledronate—osteoporosis	2.85e-05	0.000429	CcSEcCtD
Dexamethasone—Pruritus—Zoledronate—osteoporosis	2.81e-05	0.000423	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Estradiol—osteoporosis	2.79e-05	0.00042	CcSEcCtD
Dexamethasone—Nausea—Ethinyl Estradiol—osteoporosis	2.79e-05	0.00042	CcSEcCtD
Dexamethasone—Insomnia—Estradiol—osteoporosis	2.77e-05	0.000417	CcSEcCtD
Dexamethasone—Vomiting—Pamidronate—osteoporosis	2.77e-05	0.000417	CcSEcCtD
Dexamethasone—Paraesthesia—Estradiol—osteoporosis	2.75e-05	0.000414	CcSEcCtD
Dexamethasone—Asthenia—Conjugated Estrogens—osteoporosis	2.74e-05	0.000414	CcSEcCtD
Dexamethasone—Rash—Pamidronate—osteoporosis	2.74e-05	0.000413	CcSEcCtD
Dexamethasone—Dermatitis—Pamidronate—osteoporosis	2.74e-05	0.000413	CcSEcCtD
Dexamethasone—Headache—Pamidronate—osteoporosis	2.72e-05	0.000411	CcSEcCtD
Dexamethasone—Diarrhoea—Zoledronate—osteoporosis	2.72e-05	0.00041	CcSEcCtD
Dexamethasone—Nausea—Risedronate—osteoporosis	2.72e-05	0.000409	CcSEcCtD
Dexamethasone—Pruritus—Conjugated Estrogens—osteoporosis	2.71e-05	0.000408	CcSEcCtD
Dexamethasone—Dyspepsia—Estradiol—osteoporosis	2.7e-05	0.000406	CcSEcCtD
Dexamethasone—Decreased appetite—Estradiol—osteoporosis	2.66e-05	0.000401	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Estradiol—osteoporosis	2.64e-05	0.000398	CcSEcCtD
Dexamethasone—Fatigue—Estradiol—osteoporosis	2.64e-05	0.000398	CcSEcCtD
Dexamethasone—Dizziness—Zoledronate—osteoporosis	2.63e-05	0.000396	CcSEcCtD
Dexamethasone—Pain—Estradiol—osteoporosis	2.62e-05	0.000394	CcSEcCtD
Dexamethasone—Diarrhoea—Conjugated Estrogens—osteoporosis	2.62e-05	0.000394	CcSEcCtD
Dexamethasone—Nausea—Pamidronate—osteoporosis	2.58e-05	0.000389	CcSEcCtD
Dexamethasone—Dizziness—Conjugated Estrogens—osteoporosis	2.53e-05	0.000381	CcSEcCtD
Dexamethasone—Vomiting—Zoledronate—osteoporosis	2.53e-05	0.000381	CcSEcCtD
Dexamethasone—Feeling abnormal—Estradiol—osteoporosis	2.52e-05	0.00038	CcSEcCtD
Dexamethasone—Rash—Zoledronate—osteoporosis	2.51e-05	0.000377	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Estradiol—osteoporosis	2.5e-05	0.000377	CcSEcCtD
Dexamethasone—Dermatitis—Zoledronate—osteoporosis	2.5e-05	0.000377	CcSEcCtD
Dexamethasone—Headache—Zoledronate—osteoporosis	2.49e-05	0.000375	CcSEcCtD
Dexamethasone—Vomiting—Conjugated Estrogens—osteoporosis	2.43e-05	0.000366	CcSEcCtD
Dexamethasone—Urticaria—Estradiol—osteoporosis	2.43e-05	0.000366	CcSEcCtD
Dexamethasone—Abdominal pain—Estradiol—osteoporosis	2.42e-05	0.000365	CcSEcCtD
Dexamethasone—Body temperature increased—Estradiol—osteoporosis	2.42e-05	0.000365	CcSEcCtD
Dexamethasone—Rash—Conjugated Estrogens—osteoporosis	2.41e-05	0.000363	CcSEcCtD
Dexamethasone—Dermatitis—Conjugated Estrogens—osteoporosis	2.41e-05	0.000363	CcSEcCtD
Dexamethasone—Headache—Conjugated Estrogens—osteoporosis	2.4e-05	0.000361	CcSEcCtD
Dexamethasone—Nausea—Zoledronate—osteoporosis	2.36e-05	0.000356	CcSEcCtD
Dexamethasone—Nausea—Conjugated Estrogens—osteoporosis	2.27e-05	0.000342	CcSEcCtD
Dexamethasone—Asthenia—Estradiol—osteoporosis	2.2e-05	0.000331	CcSEcCtD
Dexamethasone—Pruritus—Estradiol—osteoporosis	2.17e-05	0.000326	CcSEcCtD
Dexamethasone—Diarrhoea—Estradiol—osteoporosis	2.09e-05	0.000316	CcSEcCtD
Dexamethasone—Dizziness—Estradiol—osteoporosis	2.02e-05	0.000305	CcSEcCtD
Dexamethasone—Vomiting—Estradiol—osteoporosis	1.95e-05	0.000293	CcSEcCtD
Dexamethasone—Rash—Estradiol—osteoporosis	1.93e-05	0.000291	CcSEcCtD
Dexamethasone—Dermatitis—Estradiol—osteoporosis	1.93e-05	0.000291	CcSEcCtD
Dexamethasone—Headache—Estradiol—osteoporosis	1.92e-05	0.000289	CcSEcCtD
Dexamethasone—Nausea—Estradiol—osteoporosis	1.82e-05	0.000274	CcSEcCtD
Dexamethasone—CYP2C9—Metabolism—OXCT1—osteoporosis	3.74e-06	9.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CA2—osteoporosis	3.74e-06	9.99e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TPI1—osteoporosis	3.74e-06	9.99e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PSMA5—osteoporosis	3.73e-06	9.98e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PSMA2—osteoporosis	3.73e-06	9.98e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GPX1—osteoporosis	3.73e-06	9.97e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PSMA2—osteoporosis	3.7e-06	9.89e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PSMA5—osteoporosis	3.7e-06	9.89e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MGLL—osteoporosis	3.67e-06	9.82e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GAPDH—osteoporosis	3.67e-06	9.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MGLL—osteoporosis	3.64e-06	9.74e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ADCY5—osteoporosis	3.6e-06	9.63e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—P4HB—osteoporosis	3.59e-06	9.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.58e-06	9.56e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—RAP1A—osteoporosis	3.57e-06	9.55e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL6—osteoporosis	3.56e-06	9.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—POMC—osteoporosis	3.54e-06	9.48e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TPI1—osteoporosis	3.53e-06	9.43e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GAPDH—osteoporosis	3.53e-06	9.43e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—P4HB—osteoporosis	3.52e-06	9.41e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—P4HB—osteoporosis	3.51e-06	9.39e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SPP1—osteoporosis	3.48e-06	9.32e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ACP5—osteoporosis	3.48e-06	9.3e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GAPDH—osteoporosis	3.45e-06	9.23e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO1—osteoporosis	3.45e-06	9.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GAPDH—osteoporosis	3.45e-06	9.22e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—MTHFR—osteoporosis	3.44e-06	9.2e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO1—osteoporosis	3.44e-06	9.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.44e-06	9.19e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—RAP1A—osteoporosis	3.43e-06	9.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.43e-06	9.18e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—POMC—osteoporosis	3.43e-06	9.17e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—VDR—osteoporosis	3.43e-06	9.16e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PSMA2—osteoporosis	3.4e-06	9.09e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PSMA5—osteoporosis	3.4e-06	9.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—IDH2—osteoporosis	3.4e-06	9.08e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PSMA2—osteoporosis	3.39e-06	9.07e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PSMA5—osteoporosis	3.39e-06	9.07e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—RAP1A—osteoporosis	3.36e-06	8.99e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—RAP1A—osteoporosis	3.36e-06	8.98e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PKM—osteoporosis	3.34e-06	8.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FDPS—osteoporosis	3.34e-06	8.94e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CYP19A1—osteoporosis	3.33e-06	8.9e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—P4HB—osteoporosis	3.32e-06	8.87e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—IDH2—osteoporosis	3.31e-06	8.86e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GAPDH—osteoporosis	3.26e-06	8.71e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TPI1—osteoporosis	3.24e-06	8.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP27A1—osteoporosis	3.19e-06	8.54e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—RAP1A—osteoporosis	3.17e-06	8.48e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPD2—osteoporosis	3.17e-06	8.47e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PGLS—osteoporosis	3.17e-06	8.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CALCA—osteoporosis	3.17e-06	8.47e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IRS2—osteoporosis	3.15e-06	8.43e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—POMC—osteoporosis	3.14e-06	8.38e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ADCY5—osteoporosis	3.12e-06	8.35e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—IDH2—osteoporosis	3.12e-06	8.35e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.12e-06	8.33e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP27A1—osteoporosis	3.12e-06	8.33e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GPX1—osteoporosis	3.11e-06	8.32e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ACP5—osteoporosis	3.11e-06	8.3e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—POMC—osteoporosis	3.1e-06	8.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—IDH2—osteoporosis	3.1e-06	8.28e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—LEP—osteoporosis	3.08e-06	8.24e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.07e-06	8.2e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.06e-06	8.18e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.05e-06	8.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—P4HB—osteoporosis	3.04e-06	8.13e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ACP5—osteoporosis	3.03e-06	8.1e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP19A1—osteoporosis	3.03e-06	8.1e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—osteoporosis	3.02e-06	8.07e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TGFB1—osteoporosis	3.01e-06	8.05e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP19A1—osteoporosis	3e-06	8.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GAPDH—osteoporosis	2.99e-06	7.98e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ESR1—osteoporosis	2.94e-06	7.87e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.94e-06	7.85e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.91e-06	7.78e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—RAP1A—osteoporosis	2.91e-06	7.77e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ATIC—osteoporosis	2.9e-06	7.75e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PNP—osteoporosis	2.9e-06	7.75e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO1—osteoporosis	2.89e-06	7.72e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TPI1—osteoporosis	2.89e-06	7.72e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KL—osteoporosis	2.88e-06	7.69e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—MTHFR—osteoporosis	2.87e-06	7.68e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ACP5—osteoporosis	2.86e-06	7.64e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.86e-06	7.63e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.85e-06	7.62e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PSMA5—osteoporosis	2.85e-06	7.61e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PSMA2—osteoporosis	2.85e-06	7.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ACP5—osteoporosis	2.83e-06	7.57e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	2.83e-06	7.56e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ADCY5—osteoporosis	2.82e-06	7.55e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TPI1—osteoporosis	2.82e-06	7.53e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GPX1—osteoporosis	2.81e-06	7.52e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—osteoporosis	2.8e-06	7.49e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.8e-06	7.48e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TGFB1—osteoporosis	2.79e-06	7.47e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO1—osteoporosis	2.78e-06	7.42e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-06	7.39e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—POMC—osteoporosis	2.75e-06	7.36e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IRS1—osteoporosis	2.75e-06	7.36e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP19A1—osteoporosis	2.75e-06	7.35e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PSMA5—osteoporosis	2.74e-06	7.31e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PSMA2—osteoporosis	2.74e-06	7.31e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ADCY5—osteoporosis	2.72e-06	7.27e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO1—osteoporosis	2.72e-06	7.27e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—P4HB—osteoporosis	2.72e-06	7.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO1—osteoporosis	2.71e-06	7.26e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GPX1—osteoporosis	2.71e-06	7.25e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PSMA2—osteoporosis	2.68e-06	7.16e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PSMA5—osteoporosis	2.68e-06	7.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PSMA2—osteoporosis	2.67e-06	7.15e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PSMA5—osteoporosis	2.67e-06	7.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GAPDH—osteoporosis	2.67e-06	7.12e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TPI1—osteoporosis	2.66e-06	7.1e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—P4HB—osteoporosis	2.65e-06	7.08e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—POMC—osteoporosis	2.65e-06	7.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TPI1—osteoporosis	2.63e-06	7.04e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—ESR1—osteoporosis	2.62e-06	7e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GAPDH—osteoporosis	2.6e-06	6.95e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MTHFR—osteoporosis	2.6e-06	6.94e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—RAP1A—osteoporosis	2.6e-06	6.94e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6R—osteoporosis	2.58e-06	6.91e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO1—osteoporosis	2.56e-06	6.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IGF1—osteoporosis	2.55e-06	6.81e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.54e-06	6.78e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—RAP1A—osteoporosis	2.53e-06	6.77e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PSMA2—osteoporosis	2.53e-06	6.75e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PSMA5—osteoporosis	2.53e-06	6.75e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MTHFR—osteoporosis	2.5e-06	6.69e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—P4HB—osteoporosis	2.5e-06	6.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—P4HB—osteoporosis	2.48e-06	6.62e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ADCY5—osteoporosis	2.47e-06	6.61e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GPX1—osteoporosis	2.47e-06	6.59e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CA2—osteoporosis	2.46e-06	6.59e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—OXCT1—osteoporosis	2.46e-06	6.59e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ADCY5—osteoporosis	2.45e-06	6.56e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GAPDH—osteoporosis	2.45e-06	6.55e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GPX1—osteoporosis	2.44e-06	6.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GAPDH—osteoporosis	2.43e-06	6.5e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MGLL—osteoporosis	2.4e-06	6.42e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—RAP1A—osteoporosis	2.39e-06	6.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—RAP1A—osteoporosis	2.37e-06	6.33e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—osteoporosis	2.36e-06	6.3e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO1—osteoporosis	2.35e-06	6.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PSMA5—osteoporosis	2.32e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PSMA2—osteoporosis	2.32e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP19A1—osteoporosis	2.31e-06	6.17e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—POMC—osteoporosis	2.3e-06	6.14e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MTHFR—osteoporosis	2.28e-06	6.08e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IL6—osteoporosis	2.27e-06	6.06e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.26e-06	6.05e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MTHFR—osteoporosis	2.26e-06	6.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ADCY5—osteoporosis	2.25e-06	6.02e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ADCY5—osteoporosis	2.25e-06	6.01e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GPX1—osteoporosis	2.24e-06	5.99e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP19A1—osteoporosis	2.22e-06	5.93e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP19A1—osteoporosis	2.17e-06	5.81e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.17e-06	5.8e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL6—osteoporosis	2.11e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO1—osteoporosis	2.1e-06	5.61e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—POMC—osteoporosis	2.08e-06	5.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTHFR—osteoporosis	2.07e-06	5.54e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PSMA5—osteoporosis	2.07e-06	5.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PSMA2—osteoporosis	2.07e-06	5.53e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MTHFR—osteoporosis	2.07e-06	5.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.06e-06	5.52e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP19A1—osteoporosis	2.05e-06	5.48e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO1—osteoporosis	2.05e-06	5.47e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—IDH2—osteoporosis	2.04e-06	5.46e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PSMA2—osteoporosis	2.02e-06	5.39e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PSMA5—osteoporosis	2.02e-06	5.39e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—POMC—osteoporosis	2e-06	5.35e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IRS2—osteoporosis	1.97e-06	5.27e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO1—osteoporosis	1.93e-06	5.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.92e-06	5.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO1—osteoporosis	1.91e-06	5.11e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.9e-06	5.08e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.9e-06	5.08e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ADCY5—osteoporosis	1.89e-06	5.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PSMA2—osteoporosis	1.89e-06	5.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PSMA5—osteoporosis	1.89e-06	5.04e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GPX1—osteoporosis	1.88e-06	5.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.88e-06	5.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ACP5—osteoporosis	1.87e-06	4.99e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—POMC—osteoporosis	1.82e-06	4.86e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ADCY5—osteoporosis	1.81e-06	4.85e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GPX1—osteoporosis	1.81e-06	4.83e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—POMC—osteoporosis	1.8e-06	4.82e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ADCY5—osteoporosis	1.78e-06	4.75e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ADCY5—osteoporosis	1.77e-06	4.74e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GPX1—osteoporosis	1.77e-06	4.73e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GPX1—osteoporosis	1.77e-06	4.72e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TPI1—osteoporosis	1.74e-06	4.64e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTHFR—osteoporosis	1.74e-06	4.64e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IRS1—osteoporosis	1.72e-06	4.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.68e-06	4.48e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ADCY5—osteoporosis	1.67e-06	4.48e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GPX1—osteoporosis	1.67e-06	4.46e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTHFR—osteoporosis	1.67e-06	4.46e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—POMC—osteoporosis	1.65e-06	4.42e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP19A1—osteoporosis	1.64e-06	4.38e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTHFR—osteoporosis	1.63e-06	4.37e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—P4HB—osteoporosis	1.63e-06	4.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—osteoporosis	1.63e-06	4.36e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6R—osteoporosis	1.62e-06	4.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.6e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.56e-06	4.17e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.54e-06	4.12e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—osteoporosis	1.54e-06	4.12e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ADCY5—osteoporosis	1.54e-06	4.1e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—osteoporosis	1.53e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GPX1—osteoporosis	1.53e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.53e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—osteoporosis	1.53e-06	4.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—osteoporosis	1.41e-06	3.78e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—POMC—osteoporosis	1.39e-06	3.71e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ADCY5—osteoporosis	1.37e-06	3.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GPX1—osteoporosis	1.37e-06	3.65e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—osteoporosis	1.36e-06	3.64e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ADCY5—osteoporosis	1.34e-06	3.58e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—POMC—osteoporosis	1.33e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GPX1—osteoporosis	1.33e-06	3.56e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—POMC—osteoporosis	1.31e-06	3.49e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—POMC—osteoporosis	1.3e-06	3.49e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO1—osteoporosis	1.26e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ADCY5—osteoporosis	1.26e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—osteoporosis	1.26e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GPX1—osteoporosis	1.26e-06	3.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ADCY5—osteoporosis	1.25e-06	3.34e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GPX1—osteoporosis	1.25e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.24e-06	3.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.24e-06	3.32e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—POMC—osteoporosis	1.23e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—osteoporosis	1.23e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—osteoporosis	1.16e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—osteoporosis	1.15e-06	3.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—osteoporosis	1.15e-06	3.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—POMC—osteoporosis	1.13e-06	3.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.01e-06	2.7e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—POMC—osteoporosis	1.01e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—POMC—osteoporosis	9.84e-07	2.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—osteoporosis	9.58e-07	2.56e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—osteoporosis	9.56e-07	2.55e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—POMC—osteoporosis	9.27e-07	2.48e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—POMC—osteoporosis	9.19e-07	2.46e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ADCY5—osteoporosis	8.24e-07	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPX1—osteoporosis	8.21e-07	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—osteoporosis	7.58e-07	2.03e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—osteoporosis	7.2e-07	1.93e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—POMC—osteoporosis	6.06e-07	1.62e-05	CbGpPWpGaD
